WoodTrust Financial Corp Lowers Position in CVS Health Co. (NYSE:CVS)

WoodTrust Financial Corp cut its stake in CVS Health Co. (NYSE:CVSFree Report) by 16.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 79,730 shares of the pharmacy operator’s stock after selling 16,175 shares during the quarter. CVS Health accounts for about 1.1% of WoodTrust Financial Corp’s portfolio, making the stock its 27th biggest position. WoodTrust Financial Corp’s holdings in CVS Health were worth $6,295,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Trust Point Inc. bought a new position in shares of CVS Health in the fourth quarter worth $623,000. Heartland Bank & Trust Co bought a new stake in CVS Health during the fourth quarter valued at $288,000. DORCHESTER WEALTH MANAGEMENT Co boosted its stake in CVS Health by 4.3% during the fourth quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 124,388 shares of the pharmacy operator’s stock valued at $9,822,000 after buying an additional 5,143 shares during the period. StrategIQ Financial Group LLC purchased a new stake in CVS Health during the fourth quarter valued at about $208,000. Finally, Clay Northam Wealth Management LLC purchased a new stake in CVS Health during the fourth quarter valued at about $225,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.25% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CVS. SVB Leerink initiated coverage on CVS Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $88.00 target price on the stock. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Cantor Fitzgerald restated an “overweight” rating and issued a $87.00 price objective on shares of CVS Health in a report on Thursday, February 8th. TD Cowen decreased their target price on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating for the company in a research note on Monday, December 11th. Finally, Piper Sandler upped their price objective on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, March 15th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $89.44.

View Our Latest Stock Report on CVS Health

CVS Health Trading Up 0.7 %

CVS Health stock traded up $0.48 during trading on Wednesday, reaching $74.30. The company had a trading volume of 5,606,846 shares, compared to its average volume of 11,360,354. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.86. CVS Health Co. has a 12-month low of $64.41 and a 12-month high of $83.25. The stock’s 50 day moving average price is $76.00 and its two-hundred day moving average price is $73.72. The firm has a market capitalization of $93.50 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 1.05 and a beta of 0.52.

CVS Health (NYSE:CVSGet Free Report) last posted its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The business had revenue of $93.81 billion for the quarter, compared to analysts’ expectations of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same period in the previous year, the company posted $1.99 earnings per share. As a group, equities analysts expect that CVS Health Co. will post 8.33 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 3.58%. CVS Health’s dividend payout ratio is currently 41.18%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.